You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Taris secures $12.5m in additional financing as it launches trial of bladder drug candidate

Taris Biomedical, a Lexington-based pharmaceutical company focused on developing new treatments for bladder diseases, announced Tuesday that it has raised an additional $12.5 million in financing.

The round included existing investors Flagship Ventures, Flybridge Capital Partners, Polaris Partners, and Third Rock Ventures. With this round, Taris has now raised $49.8 million to date, the company said in a press release.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week